The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis

MR Burke, I Sotiropoulos, CL Waites - Trends in Neurosciences, 2024 - cell.com
Chronic stress and the accompanying long-term elevation of glucocorticoids (GCs), the
stress hormones of the body, increase the risk and accelerate the progression of Alzheimer's …

[HTML][HTML] Glucocorticoid impairs mitochondrial quality control in neurons

GE Choi, HJ Han - Neurobiology of disease, 2021 - Elsevier
Neurons are particularly vulnerable to mitochondrial dysfunction due to high energy demand
and an inability to proliferate. Therefore, dysfunctional mitochondria cause various …

Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive …

K Grychowska, U López-Sánchez… - Journal of Medicinal …, 2023 - ACS Publications
The multifactorial origin and neurochemistry of Alzheimer's disease (AD) call for the
development of multitarget treatment strategies. We report a first-in-class triple acting …

Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways

G Canet, E Zub, C Zussy, C Hernandez… - …, 2022 - Wiley Online Library
Objective Although epilepsies and neurodegenerative disorders show pathophysiological
similarities, their direct functional associations are unclear. Here, we tested the hypothesis …

Elucidation of Pharmacological Mechanism Underlying the Anti-Alzheimer's Disease Effects of Evodia rutaecarpa and Discovery of Novel Lead Molecules: An In …

L Zhang, J Xu, J Guo, Y Wang, Q Wang - Molecules, 2023 - mdpi.com
Alzheimer's disease (AD) is a brain disease with a peculiarity of multiformity and an
insidious onset. Multiple-target drugs, especially Chinese traditional medicine, have …

Astragaloside IV ameliorates cognitive impairment and neuroinflammation in an oligomeric Aβ induced Alzheimer's disease mouse model via inhibition of microglial …

F Chen, D Yang, XY Cheng, H Yang… - Biological and …, 2021 - jstage.jst.go.jp
Microglial activation and neuroinflammation induced by amyloid β (Aβ) play pivotal roles in
Alzheimer's disease (AD) pathogenesis. Astragaloside IV (AS-IV) is one of the major active …

[HTML][HTML] New insights in drug development for Alzheimer's disease based on microglia function

O Qiao, H Ji, Y Zhang, X Zhang, X Zhang, N Liu… - Biomedicine & …, 2021 - Elsevier
One of the biggest challenges in drug development for Alzheimer's disease (AD) is how to
effectively remove deposits of amyloid-beta (Aβ). Recently, the relationship between …

The pathomimetic oAβ25–35 model of Alzheimer's disease: Potential for screening of new therapeutic agents

G Canet, C Zussy, C Hernandez, T Maurice… - Pharmacology & …, 2023 - Elsevier
Alzheimer's disease (AD) is the most common form of dementia in the elderly, currently
affecting more than 40 million people worldwide. The two main histopathological hallmarks …

Ginsenoside Rg1, lights up the way for the potential prevention of Alzheimer's disease due to its therapeutic effects on the drug-controllable risk factors of Alzheimer's …

J Wu, L Zhang, D Liu, J Xia, Y Yang, F Tang… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance In traditional Chinese medicine, Shen Nong,
BenCao Jing, and Compendium of Materia Medica (Bencao Gangmu), Panax ginseng, and …

Transcriptional glucocorticoid effects in the brain: Finding the relevant target genes

OC Meijer, JC Buurstede, EMG Viho… - Journal of …, 2023 - Wiley Online Library
Glucocorticoids are powerful modulators of brain function. They act via mineralocorticoid
and glucocorticoid receptors (MR and GR). These are best understood as transcription …